Allogeneic SCT of CordIn™, in Patients With Hemoglobinopathies

Summary

CordIn™ is a cryopreserved stem/progenitor cell-based product of purified CD133+ cells composed of ex vivo expanded allogeneic UCB cells. The overall study objectives are to evaluate the safety and efficacy of CordIn™.

Timeline

Start

2016-04-04

Primary completion

2016-08

Completion

2017-12

Outcome

Outcome not reported

Stopped (Enrollment): “lack of recruitment”

Drugs

Indications